Identification of a novel HOOK3-FGFR1 fusion gene involved in

Cytogenetic and molecular identification of CUX1 as a fusion partner of

Frontiers The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma - ScienceDirect

Upregulation of MYC in human cell-derived SCLL models Quantitative

RNA Sequencing Reveals Novel Oncogenic Fusions and Depicts Detailed Fusion Transcripts of FN1-FGFR1 in Phosphaturic Mesenchymal Tumors - Modern Pathology

Fibroblast growth factor receptor fusions in cancer: opportunities and challenges

PPT) Rentas Financieras Jean Christian Chavarri Vigo

Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway, Cancer Cell International

Identification Of A Novel HOOK3-FGFR1 Fusion Gene Involved, 48% OFF

Ponatinib inhibits molecular signaling downstream of chimeric FGFR1.

Fibroblast growth factor receptor fusions in cancer: opportunities and challenges

Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities

Endogenous Hook3 and KIF1C interact specifically. (A) Domain

14 amino acids in the tail of KIF1C mediate its interaction with Hook3.

HOOK3-FGFR1 fusion gene involved in the activation of NF-kappaB